Skip to main content
BioCentury Innovations
< Next Issue 1 2 3 4 5 Prior Issue >
As published Thursday, July 28, 2016

By Lauren Martz, Senior Writer

On the heels of cancer immunotherapy's clinical success, NK cells - a long-known but underappreciated component of the innate immune system - are emerging as the hottest new tool to fight cancer, with the potential to be safer and more broadly effective than their adaptive immune system counterparts.

The excitement centers on the potential of NK cells to solve some of the challenges of chimeric antigen receptor (CAR) T cells, allowing companies to bring together the immune system's innate and adaptive arms in a more comprehensive approach to creating tumor immunotherapies.